BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22781865)

  • 1. Testing multiple levels of influence in the intergenerational transmission of alcohol disorders from a developmental perspective: the example of alcohol use promoting peers and μ-opioid receptor M1 variation.
    Chassin L; Lee MR; Cho YI; Wang FL; Agrawal A; Sher KJ; Lynskey MT
    Dev Psychopathol; 2012 Aug; 24(3):953-67. PubMed ID: 22781865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents.
    Miranda R; Reynolds E; Ray L; Justus A; Knopik VS; McGeary J; Meyerson LA
    Alcohol Clin Exp Res; 2013 Feb; 37(2):325-31. PubMed ID: 23136901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.
    Hartwell EE; Feinn R; Morris PE; Gelernter J; Krystal J; Arias AJ; Hoffman M; Petrakis I; Gueorguieva R; Schacht JP; Oslin D; Anton RF; Kranzler HR
    Addiction; 2020 Aug; 115(8):1426-1437. PubMed ID: 31961981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.
    van den Wildenberg E; Wiers RW; Dessers J; Janssen RG; Lambrichs EH; Smeets HJ; van Breukelen GJ
    Alcohol Clin Exp Res; 2007 Jan; 31(1):1-10. PubMed ID: 17207095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol Consumption in Healthy OPRM1 G Allele Carriers and Its Association with Impulsive Behavior.
    Pfeifer P; Sariyar M; Eggermann T; Zerres K; Vernaleken I; Tüscher O; Fehr C
    Alcohol Alcohol; 2015 Jul; 50(4):379-84. PubMed ID: 25836994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction Between the μ-Opioid Receptor Gene and the Number of Heavy-Drinking Peers on Alcohol Use.
    Zaso MJ; Maisto SA; Glatt SJ; Belote JM; Park A
    Alcohol Clin Exp Res; 2017 Dec; 41(12):2041-2050. PubMed ID: 28992386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial evidence of an association between OPRM1 and adolescent alcohol misuse.
    Miranda R; Ray L; Justus A; Meyerson LA; Knopik VS; McGeary J; Monti PM
    Alcohol Clin Exp Res; 2010 Jan; 34(1):112-22. PubMed ID: 19860800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
    Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
    Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
    Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
    Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption.
    Rouvinen-Lagerström N; Lahti J; Alho H; Kovanen L; Aalto M; Partonen T; Silander K; Sinclair D; Räikkönen K; Eriksson JG; Palotie A; Koskinen S; Saarikoski ST
    Alcohol Alcohol; 2013; 48(5):519-25. PubMed ID: 23729673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPRM1 A118G and serum β-endorphin interact with sex and digit ratio (2D:4D) to influence risk and course of alcohol dependence.
    Gegenhuber B; Weinland C; Kornhuber J; Mühle C; Lenz B
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1418-1428. PubMed ID: 30322771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex.
    Kleinjan M; Poelen EA; Engels RC; Verhagen M
    Addict Biol; 2013 Nov; 18(6):1003-12. PubMed ID: 22260295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects.
    Bach P; Vollsta Dt-Klein S; Kirsch M; Hoffmann S; Jorde A; Frank J; Charlet K; Beck A; Heinz A; Walter H; Sommer WH; Spanagel R; Rietschel M; Kiefer F
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1128-35. PubMed ID: 25937240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity.
    Ray LA; Bujarski S; MacKillop J; Courtney KE; Monti PM; Miotto K
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1(Suppl 1):E116-24. PubMed ID: 23240711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
    Anton RF; Voronin KK; Randall PK; Myrick H; Tiffany A
    Alcohol Clin Exp Res; 2012 Nov; 36(11):2000-7. PubMed ID: 22551036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of OPRM1 polymorphism in the etiology of alcoholism.
    Samochowiec A; Samochowiec J; Pełka-Wysiecka J; Kucharska-Mazur J; Grochans E; Jabłoński M; Bieńkowski P; Murawiec S; Małecka I; Mak M; Kołodziej Ł; Heitzman J; Grzywacz A
    Adv Clin Exp Med; 2019 Feb; 28(2):199-202. PubMed ID: 30085428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].
    Gürel ŞC; Ayhan Y; Karaaslan Ç; Akel H; Karaca RÖ; Babaoğlu MÖ; Yaşar Ü; Bozkurt A; Dilbaz N; Uluğ BD; Demir B
    Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27370058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues.
    Ray LA; Courtney KE; Hutchison KE; Mackillop J; Galvan A; Ghahremani DG
    Alcohol Clin Exp Res; 2014 Jan; 38(1):78-89. PubMed ID: 23876228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
    Anton RF; Voronin KE; Book SW; Latham PK; Randall PK; Glen WB; Hoffman M; Schacht JP
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2084-2096. PubMed ID: 32772383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (PIP5K1C) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol Use.
    Lee JS; Sorcher JL; Rosen AD; Damadzic R; Sun H; Schwandt M; Heilig M; Kelly J; Mauro KL; Luo A; Rosoff D; Muench C; Jung J; Kaminsky ZA; Lohoff FW
    Alcohol Clin Exp Res; 2018 Jun; 42(6):1034-1043. PubMed ID: 29667742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.